Need professional-grade analysis? Visit stockanalysis.com
$13.98B
26.94
2,797
4.51%
Jafron Biomedical Co Ltd (300529) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY18.70, up 6.55% from the previous close.
Over the past year, 300529 has traded between a low of CNY17.31 and a high of CNY24.54. The stock has lost 12.3% over this period. It is currently 23.8% below its 52-week high.
Jafron Biomedical Co Ltd has a market capitalization of $13.98B, with a price-to-earnings ratio of 26.94 and a dividend yield of 4.51%.
Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Side-by-side comparison against top Healthcare peers.